A study comparing joint damage in patients with RA who received early treatment and those who received delayed treatment showed that the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels tended to be significantly lower in patients who underwent early treatment. This evidence concerns the gene CRP and rheumatoid arthritis.